GPC sobre el TDAH (res.) - GuíaSalud

177 Fitzpatrick PA, Klorman R, Brumaghim JT, Borgstedt AD. Effects ofsustained-release and standard preparations of methylphenidate on attentiondeficit disorder. J Am Acad Child Adolesc Psychiatry. 1992Mar;31(2):226-34.178 Wolraich ML, Greenhill LL, Pelham W, Swanson J, Wilens T, PalumboD, et al. Randomized, controlled trial of oros methylphenidate once aday in children with attention-deficit/hyperactivity disorder. Pediatrics.2001 Oct;108(4):883-92.179 Pelham WE, Jr., Sturges J, Hoza J, Schmidt C, Bijlsma JJ, Milich R, etal. Sustained release and standard methylphenidate effects on cognitiveand social behavior in children with attention deficit disorder. Pediatrics.1987 Oct;80(4):491-501.180 Pelham WE, Jr., Greenslade KE, Vodde-Hamilton M, Murphy DA,Greenstein JJ, Gnagy EM, et al. Relative efficacy of long-acting stimulantson children with attention deficit-hyperactivity disorder: a comparisonof standard methylphenidate, sustained-release methylphenidate,sustained-release dextroamphetamine, and pemoline. Pediatrics.1990 Aug;86(2):226-37.181 Pelham WE, Gnagy EM, Burrows-Maclean L, Williams A, FabianoGA, Morrisey SM, et al. Once-a-day Concerta methylphenidate versusthree-times-daily methylphenidate in laboratory and natural settings.Pediatrics. 2001 Jun;107(6):E105.182 Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, etal. Once-daily atomoxetine treatment for children and adolescentswith attention deficit hyperactivity disorder: a randomized, placebocontrolledstudy. Am J Psychiatry. 2002 Nov;159(11):1896-901.183 Michelson D, Buitelaar JK, Danckaerts M, Gillberg C, Spencer TJ,Zuddas A, et al. Relapse prevention in pediatric patients with ADHDtreated with atomoxetine: a randomized, double-blind, placebo-controlledstudy. J Am Acad Child Adolesc Psychiatry. 2004 Jul;43(7):896-904.184 Bohnstedt BN, Kronenberger WG, Dunn DW, Giauque AL, WoodEA, Rembusch ME, et al. Investigator ratings of ADHD symptomsduring a randomized, placebo-controlled trial of atomoxetine: a comparisonof parents and teachers as informants. J Atten Disord. 2005May;8(4):153-9.185 Weiss M, Tannock R, Kratochvil C, Dunn D, Vélez-Borrás J, ThomasonC, et al. A randomized, placebo-controlled study of once-daily atomoxetinein the school setting in children with ADHD. J Am AcadChild Adolesc Psychiatry. 2005 Jul;44(7):647-55.186 Brown RT, Perwien A, Faries DE, Kratochvil CJ, Vaughan BS. Atomoxetinein the management of children with ADHD: effects on qua-Guía de práctica clínica sobre el trastorno por déficit deatención con hiperactividad (TDAH) en niños y adolescentes185